Rafferty Asset Management, LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1389426
New York, NY
Position in PTGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,199,215
-$1,728,445 QoQ
Shares Held
26,099
-44.2% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#120
of 341 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. PTGX ranks #34 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in PTGX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,199,215 | 26,099 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,927,660 | 46,752 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,560,151 | 63,661 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,970,757 | 74,827 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,451,611 | 80,543 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,140,268 | 44,257 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,685,026 | 95,467 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,044,420 | 89,876 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,608,105 | 75,270 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,920,287 | 239,208 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,847,539 | 167,795 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $5,842,687 | 350,281 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,884,377 | 285,459 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,527,901 | 153,387 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,222,246 | 295,348 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,924,662 | 346,935 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,485,575 | 314,232 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,927,665 | 208,094 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,669,402 | 165,772 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,224,983 | 69,130 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,758,936 | 39,192 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,967,778 | 75,976 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $279,699 | 13,874 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $547,400 | 28,000 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||